LL

Lei Ling

NB Ngm Biopharmaceuticals: 8 patents #1 of 12Top 9%
📍 Foster City, CA: #5 of 463 inventorsTop 2%
🗺 California: #1,514 of 60,411 inventorsTop 3%
Overall (2018): #10,509 of 503,207Top 3%
8
Patents 2018

Issued Patents 2018

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
9974833 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having pregnancy intrahepatic cholestasis Jian Luo 2018-05-22
9963494 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject Darrin Anthony Lindhout 2018-05-08
9925242 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of nonalcoholic steatohepatitis Jian Luo 2018-03-27
9895416 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having cholestasis Jian Luo 2018-02-20
9889178 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having nonalcoholic steatohepatitis Jian Luo 2018-02-13
9889177 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having primary sclerosing cholangitis Jian Luo 2018-02-13
9878008 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having bile acid diarrhea or bile acid malabsorption Jian Luo 2018-01-30
9878009 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having error of bile acid synthesis Jian Luo 2018-01-30